Fig. 4: Risk of relapse and overall survival in newly diagnosed KMT2Ar AML. | Blood Cancer Journal

Fig. 4: Risk of relapse and overall survival in newly diagnosed KMT2Ar AML.

From: Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

Fig. 4

A Cumulative incidence of relapse by subtype of KMT2Ar. B Overall survival by subtype of KMT2Ar. C Overall survival of newly diagnosed KMT2Ar AML by therapy-related status. D Landmark analysis comparing overall survival of patients with newly diagnosed KMT2Ar AML who underwent an allogeneic hematopoietic stem cell transplant following the first remission to those who did not undergo transplant.

Back to article page